Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Change in Account Payables: 2016-2024

Historic Change in Account Payables for Arcus Biosciences (RCUS) over the last 9 years, with Dec 2024 value amounting to $3.0 million.

  • Arcus Biosciences' Change in Account Payables rose 1400.00% to $13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.0 million, marking a year-over-year increase of 383.33%. This contributed to the annual value of $3.0 million for FY2024, which is 400.00% up from last year.
  • Arcus Biosciences' Change in Account Payables amounted to $3.0 million in FY2024, which was up 400.00% from -$1.0 million recorded in FY2023.
  • In the past 5 years, Arcus Biosciences' Change in Account Payables registered a high of $9.0 million during FY2020, and its lowest value of -$5.0 million during FY2021.
  • For the 3-year period, Arcus Biosciences' Change in Account Payables averaged around $3.3 million, with its median value being $3.0 million (2024).
  • In the last 5 years, Arcus Biosciences' Change in Account Payables surged by 421.44% in 2020 and then tumbled by 155.56% in 2021.
  • Yearly analysis of 5 years shows Arcus Biosciences' Change in Account Payables stood at $9.0 million in 2020, then slumped by 155.56% to -$5.0 million in 2021, then surged by 260.00% to $8.0 million in 2022, then crashed by 112.50% to -$1.0 million in 2023, then skyrocketed by 400.00% to $3.0 million in 2024.